product safety

Dyadic is using the well known industrial fungi Trichoderma longbrachiatum and Aspergillus foetidus and the fungi Chrysosporium lucknowense (C1) developed and patented by Dyadic to produce its enzymes.

On October 1, 2009 Dyadic International Inc. announced that it has received acknowledgement from the U.S. Food and Drug Administration (“FDA”) that it has no questions at this time regarding Dyadic’s conclusion that the cellulase enzyme preparation derived from a genetically modified strain of its patented and proprietary C1 organism is generally recognized as safe (“GRAS”) under the intended conditions of use. The FDA based its notification (GRAS Notice No. GRN 000292) on information provided by Dyadic as well as other information available to the FDA.

For more information, read the press release concerning the FDA notification.